Transforming growth factor β 2: A predictive marker for breast cancer

Indian Journal of Experimental Biology

Volumn 49, Issue 11, 2011, Pages 879-887

  Dave, Heena ^a   Trivedi, Sunil ^a   Shah, Manoj ^a   Shukla, Shilin ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

Breast cancer; mRNA; Prognosis; Serum; Survival; TGF 2

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STATISTICS;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER; STATISTICS AS TOPIC; TRANSFORMING GROWTH FACTOR BETA2; TUMOR MARKERS, BIOLOGICAL;

EID: 80355128286     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barcellos-Hoff M H & Akhurst R J, Transforming growth factor-_ in breast cancer: too much, too late, Breast Cancer Res, 11 (2009) 202.
2. Trivedi S, Leclercq G & Patel D, Pattern of estrogen receptor (ER) molecular polymorphism could be a marker of breast cancer prognosis, paper presented at 83rd Annual meeting of the American Association for Cancer Research, San Diago, USA, 20-23 May, 1992.
3. Arteaga C L, Inhibition of TGF33signaling in cancer therapy, Curr Opinn Genet & Dev, 16 (2006) 30.
4. de Larco J E & Todaro G J, Growth factors from murine sarcoma virus-transformed cells, Proc Natl Acad Sci, USA, 75 (1978) 4001.
5. Arteaga C L, Dugger T C & Hurd S D, The multifunctional role of transforming growth factor (TGF)-rs on mammary cell biology, Breast Cancer Res Treat, 38 (1996) 49.
6. Massague J, TGF-66signal transduction, Annu Rev Biochem, 67 (1998) 753.
7. Reiss M & Barcellos-Hoff M H, Transforming growth factor-ffin breast cancer: A working hypothesis, Breast Cancer Res Treat, 45 (1997) 81.
8. Dumont N & Arteaga C L, Transforming Growth Factor-8 and breast cancer. Tumor promoting effects of transforming growth factor-g, Breast Cancer Res, 2 (2000) 125.
9. Grau A M & Wen W, Circulating transforming growth factor-f-1 and breast cancer prognosis: results from the Shanhgai, Breast Cancer Res Treat, 112 (2008) 335.
10. Ivanovic V & Demajo M, Elevated plasma levels of TGFbeta1 levels correlate with decreased survival of metastatic breast cancer patients, Clin Chim Acta, 371 (2006) 191.
11. Wakefield L M, Letterio J J, Chen T, Danielpour D, Allison R S H, Pai L H, Denicoff A M, Noone M H, Cowan K H, O'Shaughnessy J A & Sporn M B, Transforming Growth Factor-F1 Circulates in Normal Human Plasma and Is Unchanged in Advanced Metastatic Breast Cancer, Clin Cancer Res, 1 (1995) 129.
12. Sheen-Chen S, Chen H, Sheen C, Eng H & Chen W, Serum Levels of Transforming Growth Factor L1 in Patients with Breast Cancer, Arch Surg, 136 (2001) 937.
13. Lebrecht A, Grimm C, Euller G, Ludwig E, Ulbrich E, Lantzsch T, Hefler L & Koelbl H, Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast, Int J Biol Markers, 19(3) (2004) 236.
14. Dave H, Shah M, Trivedi S & Shukla S, Prognostic utility of circulatory Transforming Growth Factor _eta 1 in breast cancer patients (communicated; unpublished work).
15. Kopp A, Jonat W, Schmahl M & Knabbe C, Transforming Growth Factor β2 (TGF-β2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen, Cancer res, 55 (1995) 4512.
16. Gorsch S M, Memoli V A, Stukel T A, Gold L I & Arrick B A, Immunohistochemical staining for ransforming Growth Factor F1 associates with disease progression in human breast cancer, Cancer Res, 52 (1992) 6949.
17. Soufla G, Porichis F, Sourvinos G, Vassilaros S & Spandidos D A, Transcriptional deregulation of VEGF, FGF2, TGF-D1, 2, 3 and cognate receptors in breast tumorigenesis, Cancer Lett, 235 (2006) 100.
18. Figueroa J D, Flanders K C & Gracia-Closas M, Expression of TGF-oosignaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics, Breast Cancer Res Treat, 121(3) (2010) 727.
19. Puchner M A, Koppen J A, Zapf S, Knabbe C & Westphal M, The influence of tamoxifen on the secretion of Transforming Growth Factor-T2 (TGF-22) in glioblastomas: In vitro and in vivo findings, Anticancer Res, 22 (2002) 45.
20. Naef M, Ishiwata T, Friess H, Buchler M W & Gold l I, Differential localization of Transforming Growth Factor-f isoforms in human gastric mucosa and over expression in gastric carcinoma, In. J Cancer, 71 (1997) 131.
21. MacCallum J, Keen J C, Bartlett J M, Thompson A M, Dixon J M & Miller W R, Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy, Br J Cancer, 74(3) (1996) 474.
22. Brandt S, Kopp A, Grage B, Knabbe C, Effects of tamoxifen on transcriptional level of Transforming Growth Factor Beta (TGF-β) Isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer, Anticancer Res, 23 (2003) 223.
23. AJCC classification, 6th Edition, Classification Chapter 25: TNM. 2002.
24. Ghayad S E, Vendrell J A, Bieche I, Spyratos F, Dumontet C, Treilleux I, Lidereau R & Cohen P A, Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer, J Mol Endocrinol, 42(2) (2009) 87.
25. Hinshelwood R A, Huschtscha L I, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells C A, Hume D A, Reddel R R & Clark S J, Concordant epigenetic silencing of transforming growth factor-beta signalling pathway genes occurs early in breast carcinogenesis, Cancer Res, 67(24) (2007) 11517.
26. Buck M B, Coller J K, Mürdter T E, Eichelbaum M & Knabbe C, TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells, Breast Cancer Res Treat, 107(1) (2008) 15.
27. Beisner J, Buck M B, Fritz P, Dippon J, Schwab M, Brauch H, Zugmaier G, Pfizenmaier K & Knabbe C, A novel functional polymorphism in the transforming growth factorbeta2 gene promoter and tumor progression in breast cancer, Cancer Res, 66(15) (2006) 7554.
28. Buck M B & Knabbe C, TGF-beta signaling in breast cancer, Ann N Y Acad Sci. 1089 (2006) 119.
29. Jaschinski F, Rothhammer T, Jachimczak P, Seitz C, Schneider A & Schlingensiepen K H, The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2, Curr Pharm Biotechnol, 2011 May 27. [Epub ahead of print]
30. Hilbig A & Oettle H, Transforming Growth Factor Beta in pancreatic cancer, Curr Pharm Biotechnol, 2011 May 27. [Epub ahead of print].
31. Schlingensiepen K H, Jaschinski F, Lang S A, Moser C, Geissler E K, Schlitt H J, Kielmanowicz M & Schneider A, Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer, Cancer Sci, 102(6) (2011) 1193.